Loading...
Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?
The treatment landscape for chronic lymphocytic leukemia (CLL) is rapidly evolving. Targeted agents (TAs) have demonstrated impressive single agent activity and therefore have been replacing chemoimmunotherapy (CIT). Despite their efficacy, the optimal use of the current TAs remains challenging. Per...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265785/ https://ncbi.nlm.nih.gov/pubmed/30429158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-08-869503 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|